View By Professional Interest Track

            Collaborative       Nurse       Practice Management       Psychology       TWP (Begins Nov. 1)

Track: Collaborative



Monday, November 2 01:00-02:15 p.m.
161 - Collaboration With Primary Care Physicians in Pain Patients PI CAM
1.25 credits - Room: Breakers IJ
Bill H. McCarberg, MD, Founding Director, Chronic Pain Management Program, Kaiser Permanente, Adjunct Assistant Clinical Professor University of California School of Medicine President Western Pain Society San Diego, CA

Primary care providers have less time to deal with an increasing number of health issues. When a patient presents with multiple complaints and persistent pain, primary care will attribute all the symptoms to the underlying psychologic stressors. Persistent pain worsens psychological adaptation and depression and anxiety make pain worse. Having a supportive relationship with primary care providers leads to better patient care and improved outcomes.

Upon the completion of this activity, participants will be able to:

  1. Describe what primary care is looking for in referring patients with persistent pain;
  2. Prepare the referring provider to care for future, similar patients; and 3) Separate the pain complaints from the psychologic issues.
Monday, November 2 01:00-02:15 p.m.
162 - Understanding and Treating Aggression in Youth CA PT
1.25 credits - Room: Mandalay Bay Ballroom CD
Robert Hendren, DO, Director of Child and Adolescent Psychiatry Vice-Chair, Department of Psychiatry UCSF; President, American Academy of Child and Adolescent Psychiatry

Aggressive behavior is the one of the most common referral problems in child and adolescent psychiatry.

By participating in this activity, attendees will be able to:

  1. List the psychiatric conditions that are associated with aggression;
  2. Discuss the biological, social and psychological factors underlying the aggressive behavior; and
  3. Identify the preventive interventions that will address building the therapeutic alliance with the parents and the adolescent, addressing the cultural issues, treating the comorbid psychiatric conditions etc.
Monday, November 2 02:30-03:45 p.m.
172 - Using the Neurodevelopmental Formulation in Clinical Practice NP CA
1.25 credits - Room: Mandalay Bay Ballroom CD
Robert Hendren, DO, Director of Child and Adolescent Psychiatry Vice-Chair, Department of Psychiatry UCSF; President, American Academy of Child and Adolescent Psychiatry

Cognitive outcome in adolescents is shaped by etiological factors and the underlying neuropathology in a range of developmental and acquired brain disorders.

Upon the completion of this activity, participants will be able to:

  1. Discuss the neuropsychological disorders in adolescents and their functional implications;
  2. Recognize the brain-behavior relationship from the prenatal period through late adolescence within the context of typical and atypical development; and
  3. Identify collaborative and consultative approaches within the context of the neuropsychological evaluation.
Tuesday, November 3 09:15-10:30 a.m.
223 - Neuropsychiatric Masquerades: Medical and Neurological Disorders that Present with Psychiatric Symptoms Part 1 NP
1.25 credits - Room: Mandalay Bay Ballroom KL
Jose Maldonado, MD, Associate Professor of Psychiatry and Behavioral Sciences; Chief, Medical and Forensic Psychiatry Section; Medical Director, Psychosomatic Medicine Service, Stanford University Medical Center

Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies.

By participating in this activity, attendees will be able to:

  1. Recognize the most common infectious disorders presenting with psychiatric symptoms;
  2. Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
  3. Recommend the research-based, effective treatment options for these conditions.
Tuesday, November 3 10:45-12:00 p.m.
233 - Neuropsychiatric Masquerades: Medical and Neurological Disorders that Present with Psychiatric Symptoms Part 2 NP
1.25 credits - Room: Mandalay Bay Ballroom KL
Jose Maldonado, MD, Associate Professor of Psychiatry and Behavioral Sciences; Chief, Medical and Forensic Psychiatry Section; Medical Director, Psychosomatic Medicine Service, Stanford University Medical Center

Psychiatric masquerades are medical and/or neurological conditions which present primarily with psychiatric or behavioral symptoms. The conditions included in this category range from neurological disorders (e.g. seizure disorders and MS), to infectious diseases (e.g. syphilis, herpes and HIV), to connective tissue disorders (e.g. vasculitis and SLE), to malignancies (e.g., paraneoplastic syndromes and pancreatic cancer), to metabolic disorders (e.g. Wilson's disease and prophyria), to various toxins and substances our patients may be exposed to. In this lecture, we will discuss the presentation and symptoms of the most common masquerades, focusing on pearls for timely diagnosis, and discuss potential management and treatment strategies.

By participating in this activity, attendees will be able to:

  1. Recognize the most common infectious disorders presenting with psychiatric symptoms;
  2. Explain the incidence, epidemiology and clinical features of the most common neuropsychiatric disorders masquerading as psychiatric illness;
  3. Recommend the research-based, effective treatment options for these conditions.
Tuesday, November 3 01:00- 02:15 p.m.
251 - Youth Suicide: Who is Most at Risk? VT PT CA
1.25 credits - Room: Mandalay Bay Ballroom IJ
Lisa Boesky, PhD, National Speaker & Author, San Diego, CA

For the first time in a decade, youth suicide is on the rise.

By participating in this activity, attendees will be able to:

  1. Identify two new trends in youth suicide and why they are so troublesome;
  2. List both the subtle and obvious factors leading to suicide in children and teens-including the "Big 3"; and
  3. Describe the four essential parts of suicide screening of youth.
Tuesday, November 3 05:45- 07:00 p.m.
264 - How to Take an Environmental Exposure History: Signs and Symptoms of Sensitivity in Psychiatric Patients. PD
1.25 credits - Room: Breakers CD
Lisa Lavine Nagy, MD, President, The Preventive and Environmental Health Alliance (PEHA)

Upon the completion of this activity, participants will be able to:

  1. Recognize patients with environmental sensitivities by asking a few screening questions.
  2. Help the patient determine what environmental factors are or have potentially affected their health. Focusing on mold at home or work as a common culprit.
  3. Recognize adrenal insufficiency, dysautonomia, mitochondrial compromise and chemical sensitivity in your patients and obtaining proper referral for these conditions in your area.
Tuesday, November 3 05:45- 07:00 p.m.
265 - An Update in TIA and Stroke NP
1.25 credits - Room: Lagoon ABCGHI
Laurence Kinsella, MD, FAAN, Professor of Neurology, St. Louis University; Chief, Division of Neurology and Neurophysiology, Forest Park Hospital, St. Louis

Upon the completion of this activity participants will be able to:

  1. Apply evidence-based medicine to the treatment of TIA and Stroke;
  2. Learn different stroke subtypes, risk factors, and clinical syndromes;
  3. Discuss new definition of TIA; and
  4. Understand the role of intravenous vs. intra-arterial thrombolysis in acute stroke.
Wednesday, November 4 07:45- 09:00 a.m.
313 - War Trauma: Helping Our Veterans Truly "Come Home"- Interventions for the Family, the Neighborhoods, the Schools, the Employers, and the Religious Community VT PT
1.25 credits - Room: Lagoon EFKL
Tom Smith, MS Psych, PD, FASCP, LMHC, NCP, President and CEO, Smith Rehabilitation Consultants, Inc.
Barbara Smith, JD, Of Counsel, Chief Operating Officer, and Executive Vice President of Smith Rehabilitation Consultants, Inc

Iraq and Afghanistan veterans are returning home. Because so many are reservists, they will be coming back into civilian life.The prevalence of mental health disorders in these returning veterans is significant and very different in the clinical presentation than others with such conditions as PTSD. This seminar will address the identification of those veterans and their families in need, clinical interventions, and problems/solutions that therapists may face in providing services at all stages of the war experience, pre-deployment, deployment, and the return home.

By participating in this activity, participants will be able to:

  1. Understand the importance of providing psychological, social, and/or psychiatric support for families of servicemen and service women in the different phases of War.
  2. Appreciate the need for varied services (including addressing legal issues) to be delivered in different settings, including schools, work, places of worship, etc.
  3. Gain further knowledge treating multiaxial aspects of the serviceman or service woman- and their families.
Thursday, November 5 10:45-12:00 p.m.
437 - Motion in Emotion: Science and Art of Bringing Physical Exercise into your Treatment Plan PD CAM
1.25 credits - Room: Mandalay Bay Ballroom CD
Rakesh Jain, MD, MPH, Director of Psychiatric Drug Research, R/D Clinical Research Center, Lake Jackson, Texas
Charles Raison, MD, Associate Professor Clinical Director Mind-Body Program Department of Psychiatry and Behavioral Sciences Emory University School of Medicine Atlanta, GA

Does "Motion', that is, exercise have a place in our treatment armamentarium? This is a question all clinicians have frequently asked of themselves. The last decade of clinical and animal research has revealed surprising powerful positive effects of exercise on mood disorders. We now know that exercise affects brain volume, inflammatory cytokines, and the autonomic system. Clinical research data also points to exercise's powerful anti-depressant effects. In light of these exciting findings, this seminar is aimed at providing clinicians the research findings, as will as provide attendees with tools on how to "prescribe" exercise to their patients. Clinicians will be provided with tools to assist them in implementing an exercise prescribing program in their practices.

Upon the completion of the this activity, participants will be able to:

  1. Develop an scientifically and data based appreciation of the complex neurobiology of exercise's positive effects on  on mood.
  2. Examine the clinical, randomized data of exercise treatment in mood disorder and develop practical skills in applying this information to clinical care of patients.

  Terms of Service     Privacy     Advertising
  ©2009 CME LLC